Novonesis (Novozymes) B (0Q4U) - Analysis

United States

opens in 1d 17h 45m

005930 219,500.00 -2.23%
0700 494.80 -0.08%
2330 2,185.00 5.05%
ASML 1,249.60 2.11%
AZN 13,956.00 -3.70%
ETH/USD 2,307.22 -0.34%
EUR/USD 1.17 0.01%
MC 471.65 -0.75%
NESN 81.15 1.45%
USD/JPY 159.38 0.01%
XPT/USD 1,003.20 0.33%

005930 219,500.00 -2.23%
0700 494.80 -0.08%
2330 2,185.00 5.05%
ASML 1,249.60 2.11%
AZN 13,956.00 -3.70%
ETH/USD 2,307.22 -0.34%
EUR/USD 1.17 0.01%
MC 471.65 -0.75%
NESN 81.15 1.45%
USD/JPY 159.38 0.01%
XPT/USD 1,003.20 0.33%

005930 219,500.00 -2.23%
0700 494.80 -0.08%
2330 2,185.00 5.05%
ASML 1,249.60 2.11%
AZN 13,956.00 -3.70%
ETH/USD 2,307.22 -0.34%
EUR/USD 1.17 0.01%
MC 471.65 -0.75%
NESN 81.15 1.45%
USD/JPY 159.38 0.01%
XPT/USD 1,003.20 0.33%

005930 219,500.00 -2.23%
0700 494.80 -0.08%
2330 2,185.00 5.05%
ASML 1,249.60 2.11%
AZN 13,956.00 -3.70%
ETH/USD 2,307.22 -0.34%
EUR/USD 1.17 0.01%
MC 471.65 -0.75%
NESN 81.15 1.45%
USD/JPY 159.38 0.01%
XPT/USD 1,003.20 0.33%

385.45001 DKK

1.1

0.29%

Last update Apr 24, 4:29 PM BST

Market closed

Day range

385.45001

382.5

386.64999

Previous close

384.35001

Open

385.39999

Access this stock data via API

Novonesis (Novozymes) B

385.45

1.10

0.29%

Analysis

Growth estimates
Current qtr (Apr 2026)	0.268%
Next qtr. (Jul 2026)	0.077%
Current year (2026)	0.133%
Next 5 years (per annum)	0.084%
Past 5 years (per annum)	0.025%

Access /growth_estimates data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

Access /recommendations data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.

Analyst ratings

Firm	Date	Action
JP Morgan	Mar 26, 2019	Downgrade
Jefferies	Aug 07, 2015	Maintains

Access /analyst_ratings/light data via our API — starting from the Ultra plan (individual) and the Enterprise plan (business) and above.